Hopes rise for patients with drug resistant HIV

New treatments may soon be available for patients with HIV which has become resistant to existing treatments.

The results are from completed phase III trials of a new category of anti-HIV drug called “fusion inhibitors.” The results show that twice as many patients using the first fusion inhibitor, T-20, in combination with antiretroviral drugs, achieved reductions in their viral load to below detectable levels, compared with patients taking antiretroviral drugs alone.

Significant improvements in immune cell (CD4) counts …